Riboflavin 5 Phosphate Sodium

Weekly News Recap
#Phispers

Stock Recap
#PipelineProspector

Virtual Booth

Contact Supplier

Access all COS suppliers
Check all USDMF suppliers

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

20 API Suppliers, 7 USDMF, 3 CEP/COS, 5 JDMF, 2 EU WC, 9 NDC API, 7 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

FINISHED DOSAGE FORMULATIONS

33 FDF Dossiers, 13 FDA Orange Book, 15 Europe, 2 South Africa, 3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL, SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML, SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML, INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL, INJECTABLE;INJECTION - 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 3 Rochem International Inc, 14 SPI Pharma, 6 DKSH, 1 Pharm-RX Chemical, 3 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 5 Kirsch Pharma, 4 ACG Worldwide, 6 Actylis, 4 BASF, 1 Bioplus Life Sciences, 1 CD Formulation, 2 Finar, 6 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 1 Kerry, 3 Lonza Capsugel, 2 Microlex e.U, 1 Nanjing Bold Chemical, 3 Pluviaendo, 1 Qualicaps, 14 Roquette, 8 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

25 Fillers, Diluents & Binders, 25 Parenteral, 18 Solubilizers, 17 Taste Masking, 14 Film Formers & Plasticizers, 13 Chewable & Orodispersible Aids, 12 Topical, 11 Direct Compression, 11 Thickeners and Stabilizers, 8 Empty Capsules, 7 Coating Systems & Additives, 7 Disintegrants & Superdisintegrants, 6 Surfactant & Foaming Agents, 5 Emulsifying Agents, 4 Co-Processed Excipients, 3 Granulation, 2 Coloring Agents, 1 Rheology Modifiers, 1 Soft Gelatin, 1 API Stability Enhancers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 1 Stock Recap #PipelineProspector, 4 News #PharmaBuzz

MARKET PLACE

16 APIs, 1 EXCIPIENTS

Xls

Filters

Company Name

Year

DEALS // DEV.

Country

Sponsor

Therapeutic Area

Study Phase

Deal Type

Product Type

Dosage Form

Lead Product

Target

Filters

Reset Filter

All Developments

Therapeutic Area by Lead Product

Study Phase by Lead Product

Company by Lead Product

Top Deals by Deal Size (USD bn)

Reset All

01

Glaukos

U.S.A

Neuroscience

Not Confirmed

Find Clinical Drug Pipeline Developments & Deals for Riboflavin 5 Phosphate Sodium